David O. Nettleton

1.1k total citations
30 papers, 865 citations indexed

About

David O. Nettleton is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, David O. Nettleton has authored 30 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Immunology. Recurrent topics in David O. Nettleton's work include Pharmacogenetics and Drug Metabolism (3 papers), Chemical Synthesis and Analysis (3 papers) and Bacteriophages and microbial interactions (3 papers). David O. Nettleton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Chemical Synthesis and Analysis (3 papers) and Bacteriophages and microbial interactions (3 papers). David O. Nettleton collaborates with scholars based in United States, Switzerland and Germany. David O. Nettleton's co-authors include George Ordal, Odette A. Fahmi, Tristan S. Maurer, J. D. Thomson, Frédéric J. Zécri, Shaoxian Sun, Rajeshri G. Karki, Vladi V. Heredia, Shih‐Yuan Liu and Peng Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

David O. Nettleton

29 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David O. Nettleton United States 18 458 203 153 142 134 30 865
Paula R. Davis-Searles United States 8 665 1.5× 351 1.7× 235 1.5× 143 1.0× 58 0.4× 9 1.2k
Marie‐Agnès Sari France 19 674 1.5× 189 0.9× 289 1.9× 121 0.9× 106 0.8× 39 1.5k
Natallia Strushkevich Belarus 15 462 1.0× 461 2.3× 159 1.0× 156 1.1× 103 0.8× 42 1.2k
Martín Brandt United States 19 682 1.5× 61 0.3× 126 0.8× 87 0.6× 217 1.6× 45 1.2k
Shaun D. Black United States 17 917 2.0× 521 2.6× 136 0.9× 267 1.9× 51 0.4× 32 1.4k
Veronika Navrátilová Czechia 12 641 1.4× 234 1.2× 73 0.5× 99 0.7× 47 0.4× 15 988
Vikram Roongta United States 17 665 1.5× 127 0.6× 29 0.2× 150 1.1× 103 0.8× 32 1.1k
Frederick G. Walz United States 19 721 1.6× 310 1.5× 108 0.7× 137 1.0× 51 0.4× 42 992
Rock Breton Canada 18 530 1.2× 147 0.7× 348 2.3× 49 0.3× 67 0.5× 30 1.1k
Markus Voehler United States 22 904 2.0× 154 0.8× 59 0.4× 91 0.6× 271 2.0× 55 1.5k

Countries citing papers authored by David O. Nettleton

Since Specialization
Citations

This map shows the geographic impact of David O. Nettleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O. Nettleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O. Nettleton more than expected).

Fields of papers citing papers by David O. Nettleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David O. Nettleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O. Nettleton. The network helps show where David O. Nettleton may publish in the future.

Co-authorship network of co-authors of David O. Nettleton

This figure shows the co-authorship network connecting the top 25 collaborators of David O. Nettleton. A scholar is included among the top collaborators of David O. Nettleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David O. Nettleton. David O. Nettleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auld, Douglas S., et al.. (2024). Tight-Binding Small-Molecule Carboxylesterase 2 Inhibitors Reduce Intracellular Irinotecan Activation. Journal of Medicinal Chemistry. 67(3). 2019–2030. 2 indexed citations
2.
Bagdanoff, Jeffrey T., Thomas M. Smith, Martin Allan, et al.. (2023). Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands. Cell chemical biology. 30(1). 97–109.e9. 22 indexed citations
3.
Humphreys, Sara C., David O. Nettleton, Colin Phipps, et al.. (2023). Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders. Drug Metabolism and Disposition. 51(7). 792–803. 29 indexed citations
4.
Golosov, Andrei A., Jakal Amin, Charles R. Babu, et al.. (2021). Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure. Journal of Medicinal Chemistry. 64(5). 2622–2633. 22 indexed citations
5.
Zhao, Peng, David O. Nettleton, Rajeshri G. Karki, Frédéric J. Zécri, & Shih‐Yuan Liu. (2017). Medicinal Chemistry Profiling of Monocyclic 1,2‐Azaborines. ChemMedChem. 12(5). 358–361. 97 indexed citations
6.
O’Donnell, Peter, Ulf Neumann, Michael Pietropaolo, et al.. (2014). P2‐059: BACE1/2 INHIBITION DOES NOT REGULATE PANCREATIC BETA CELL FUNCTION AND MASS IN MICE. Alzheimer s & Dementia. 10(4S_Part_12). 1 indexed citations
7.
Nettleton, David O. & Heidi J. Einolf. (2011). Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development. Current Topics in Medicinal Chemistry. 11(4). 382–403. 37 indexed citations
8.
Benbow, John W., Jiri Aubrecht, Michael J. Banker, David O. Nettleton, & Michael D. Aleo. (2010). Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies☆. Toxicology Letters. 197(3). 175–182. 36 indexed citations
9.
Fahmi, Odette A., et al.. (2008). A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro. Drug Metabolism and Disposition. 36(8). 1698–1708. 161 indexed citations
10.
Posner, Bruce A., Yulong Hong, Michael J. Potchoiba, et al.. (2007). Multiplexing G protein-coupled receptors in microarrays: A radioligand-binding assay. Analytical Biochemistry. 365(2). 266–273. 9 indexed citations
11.
Chambers, Robert, John B. Cheng, Douglas A. Fisher, et al.. (2005). A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function. Bioorganic & Medicinal Chemistry Letters. 16(3). 718–721. 4 indexed citations
12.
Zhao, Sabrina X., Bill J. Smith, Daniel Meyer, et al.. (2004). Simple Strategies for Reducing Sample Loads in In Vitro Metabolic Stability High-Throughput Screening Experiments: A Comparison between Traditional, Two-Time-Point and Pooled Sample Analyses. Journal of Pharmaceutical Sciences. 94(1). 38–45. 15 indexed citations
13.
Pan, Lydia C., Philip A. Carpino, Bruce A. Lefker, et al.. (2001). Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue. Endocrine. 14(1). 121–132. 33 indexed citations
14.
Springer, Dane M., Joanne J. Bronson, Muzammil M. Mansuri, et al.. (2000). Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity. Bioorganic & Medicinal Chemistry. 8(5). 1087–1109. 6 indexed citations
15.
Springer, Dane M., Joanne J. Bronson, Muzammil M. Mansuri, David O. Nettleton, & Kenneth M. Tramposch. (1996). A simple synthesis of biaryl phospholipase A2 inhibitors: Probing hydrophobic effects. Bioorganic & Medicinal Chemistry Letters. 6(22). 2669–2672. 2 indexed citations
16.
Nettleton, David O., et al.. (1993). Swine as a model of skin inflammation. Inflammation. 17(2). 205–215. 20 indexed citations
17.
Tramposch, Kenneth M., Paul Stanley, David O. Nettleton, et al.. (1992). Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity. Biochemical and Biophysical Research Communications. 189(1). 272–279. 27 indexed citations
18.
Nettleton, David O., Philip D. Morse, & Harold M. Swartz. (1989). Exchange and shuttling of electrons by nitroxide spin labels. Archives of Biochemistry and Biophysics. 271(2). 414–423. 16 indexed citations
19.
Nettleton, David O., Philip D. Morse, Jurek Dobrucki, Harold M. Swartz, & N.J.F. Dodd. (1988). Distribution of 5-doxylstearic acid in the membranes of mammalian cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 944(2). 315–320. 17 indexed citations
20.
Bedale, Wendy, et al.. (1988). Evidence for methyl group transfer between the methyl-accepting chemotaxis proteins in Bacillus subtilis. Journal of Bacteriology. 170(1). 223–227. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula R. Davis-Searles Breakdown of academic impact, for papers by Marie‐Agnès Sari Breakdown of academic impact, for papers by Natallia Strushkevich Breakdown of academic impact, for papers by Martín Brandt Breakdown of academic impact, for papers by Shaun D. Black Breakdown of academic impact, for papers by Veronika Navrátilová Breakdown of academic impact, for papers by Vikram Roongta Breakdown of academic impact, for papers by Frederick G. Walz Breakdown of academic impact, for papers by Rock Breton Breakdown of academic impact, for papers by Markus Voehler
Rankless by CCL
2026